Isabel Solares
Overview
Explore the profile of Isabel Solares including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meijon-Ortigueira M, Solares I, Munoz-Delgado C, Stanescu S, Morado M, Pascual-Izquierdo C, et al.
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540192
Gaucher disease is an inherited disorder in which there is a deficiency of the enzyme glucocerebrosidase, which leads to the accumulation of glucosylceramide. Although much scientific evidence is now available,...
2.
Castelbon Fernandez F, Barreda Sanchez M, Arranz Canales E, Hernandez Contreras M, Solares I, Morales Conejo M, et al.
Med Clin (Barc)
. 2023 Oct;
162(3):103-111.
PMID: 37838536
Background: Acute hepatic porphyria (AHP) comprises a group of rare genetic diseases characterized by neurovisceral crises that are manifested by abdominal pain and neurological and/or psychological symptoms that interfere with...
3.
Solares I, Castelbon F, Enriquez de Salamanca R, Morales-Conejo M
Med Clin (Barc)
. 2023 Oct;
159 Suppl 1:S19-S24.
PMID: 37827888
No abstract available.
4.
Longo M, Jerico D, Cordoba K, Riezu-Boj J, Urtasun R, Solares I, et al.
Int J Mol Sci
. 2023 Aug;
24(15).
PMID: 37569315
Acute intermittent porphyria (AIP) is a metabolic disorder caused by mutations in the porphobilinogen deaminase (PBGD) gene, encoding the third enzyme of the heme synthesis pathway. Although AIP is characterized...
5.
Solares I, Jerico D, Cordoba K, Morales-Conejo M, Ena J, Enriquez de Salamanca R, et al.
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36613492
Porphobilinogen deaminase (PBGD) haploinsufficiency (acute intermittent porphyria, AIP) is characterized by neurovisceral attacks associated with high production, accumulation and urinary excretion of heme precursors, δ-aminolevulinic acid (ALA) and porphobilinogen (PBG)....
6.
Martinez-Perez D, Vinal D, Solares I, Espinosa E, Feliu J
Cancers (Basel)
. 2021 Dec;
13(23).
PMID: 34885078
Uveal melanoma is a rare neoplasm with poor prognosis in the metastatic setting. Unlike cutaneous melanoma, treatment with kinase inhibitors or immune checkpoint inhibitors is not effective. Glycoprotein 100 (Gp-100)...
7.
Solares I, Heredia-Mena C, Castelbon F, Jerico D, Cordoba K, Fontanellas A, et al.
Diagnostics (Basel)
. 2021 Nov;
11(11).
PMID: 34829496
Inborn errors of metabolism (IEM) constitute an important group of conditions characterized by an altered metabolic pathway. There are numerous guidelines for the diagnosis and management of IEMs in the...
8.
Solares I, Izquierdo-Sanchez L, Morales-Conejo M, Jerico D, Castelbon F, Cordoba K, et al.
Biomedicines
. 2021 Apr;
9(3).
PMID: 33807619
Acute porphyria attacks are associated with the strong up-regulation of hepatic heme synthesis and over-production of neurotoxic heme precursors. First-line therapy is based on carbohydrate loading. However, altered glucose homeostasis...
9.
Solares I, Tejedor M, Jerico D, Morales-Conejo M, Enriquez de Salamanca R, Fontanellas A, et al.
Ann Transl Med
. 2020 Nov;
8(17):1098.
PMID: 33145317
Hyponatremia is a common feature during the neurovisceral acute attacks which characterize hepatic porphyrias, as well as a sign of its severity. Therapeutic options for first-line acute attacks are intravenous...